Karsten Graudenz is currently the Primary Care Lead at Pfizer Germany, having previously held several leadership roles in the Inflammation and Immunology, Rare Diseases, and Pulmonary Vascular departments. With a robust background in marketing and therapeutic area leadership, Karsten has overseen important cardiovascular and respiratory products, including Sortis and Spiriva. Earlier in their career, they completed a fellowship in cardiology at the University Hospital of Münster. Karsten has been with Pfizer since 2012 and continues to drive innovation in internal medicine and hospital therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices